Research
Mixed
Standard diagnostic thresholds for natriuretic peptides (BNP/NT-proBNP) are less sensitive in individuals with obesity, potentially missing cases of HFpEF, necessitating adjusted cutoffs or alternative screening scores.
If you have obesity, standard blood tests for heart failure (BNP/NT-proBNP) might not be sensitive enough to detect early problems. Ensure your doctor interprets these results in the context of your weight or uses specialized scoring systems (like the HFpEF-ABA score) that account for obesity.
GoodQualifiesHIGH confidence
It has been demonstrated that circulating levels of natriuretic peptides are lower in individuals with obesity, regardless of the presence of acute decompensated HF.
Why this rating
Cites multiple studies showing reduced sensitivity of standard cutoffs in obese populations.
Source
Time to screen: rationale and roadmap for HFpEF screening in individuals with obesity
Anouk Achten et al. · Heart Failure Reviews · 2025
DOI 10.1007/s10741-025-10540-z
narrative_reviewCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- SGLT2 inhibitors and GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) provide clinical benefits in obesity-related HFpEF, including symptom improvement and potential reverse cardiac remodeling, independent of or in addition to weight loss.Good
- Systematic screening for heart failure with preserved ejection fraction (HFpEF) in asymptomatic or mildly symptomatic individuals with obesity is clinically indicated to enable early detection and intervention, as obesity-related HFpEF presents with distinct pathophysiology and earlier onset.Moderate
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →